The Alnylam Act® primary hyperoxaluria type 1 (PH1) program provides no-charge genetic testing for primary hyperoxaluria type 1. For details on eligibility and ordering, please visit the Alnylam Act page.
Articles in this section
- What is Behind the Seizure™?
- What is the Alnylam Act® hATTR amyloidosis program?
- What is the Alnylam Act® acute hepatic porphyrias program?
- What is the Alnylam Act® primary hyperoxaluria type 1 program?
- What is Uncovering Periodic Paralysis?
- What is SMA Identified?
- Who can I contact about possible partnerships?